Product image of Irbesartan Tecnigen (Irbesartan) supplied by GNH India

Irbesartan Tecnigen

Active Ingredient:
Irbesartan
Origin:
EU

Irbesartan Tecnigen (Irbesartan)

Irbesartan, the active ingredient in Irbesartan Tecnigen, is an angiotensin II receptor blocker presented as an oral tablet for oral use. It is used to treat chronic hypertension and to protect kidney function significantly in patients with type 2 diabetic nephropathy.

GNH India supplies Irbesartan Tecnigen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and transplant centres in over 50 countries with reliable logistics worldwide.

Manufacturer / TM Owner

Tecnigen S.R.L.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Irbesartan is an angiotensin II receptor blocker that manages conditions related to the renin‑angiotensin system.

  • Hypertension: lowers elevated blood pressure and reduces cardiovascular risk.
  • Diabetic nephropathy: slows progression of kidney disease in patients with type 2 diabetes.
  • Proteinuria: decreases urinary protein excretion, supporting renal protection.

How It Works

  • Irbesartan selectively antagonizes angiotensin II type 1 (AT1) receptors, preventing angiotensin II‑mediated vasoconstriction, aldosterone release, and sympathetic activation. This blockade leads to vasodilation, reduced sodium and water retention, and lowered blood pressure, while also providing renal protective effects in diabetic patients.

Side Effects

Common Side Effects

  • Dizziness: sensation of light‑headedness, especially after standing.
  • Headache: mild to moderate head discomfort.
  • Fatigue: general tiredness or lack of energy.
  • Nausea: feeling of stomach upset.
  • Elevated potassium: mild hyperkalaemia detectable in blood tests.
  • Upper respiratory infection: transient cold‑like symptoms.

Serious or Rare Side Effects

  • Angioedema: swelling of face, lips, tongue, or throat requiring immediate medical attention.
  • Severe hypotension: marked drop in blood pressure causing faintness.
  • Acute kidney injury: sudden decline in renal function.
  • Hepatic dysfunction: abnormal liver enzymes or hepatitis.
  • Blood dyscrasias: rare blood cell abnormalities.
  • Pancreatitis: inflammation of the pancreas with abdominal pain.

Precautions & Warnings

Irbesartan should be used with careful monitoring and patient education.

  • Blood pressure monitoring: check regularly to avoid excessive hypotension.
  • Renal function assessment: evaluate serum creatinine and eGFR before and during therapy.
  • Serum potassium checks: monitor for hyperkalaemia, especially with concomitant potassium‑sparing agents.
  • Hepatic impairment: use cautiously in patients with liver disease.
  • Pregnancy: contraindicated in pregnancy (Category D) due to fetal risk.
  • Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Irbesartan may interact with several medicines that affect blood pressure, potassium balance, or renal function.

Major Interactions (Avoid)

  • Aliskiren (in diabetes): combined use can increase renal impairment and hyperkalaemia.
  • Dual ARB/ACE inhibitor therapy: heightened risk of hypotension and renal dysfunction.
  • Potassium‑sparing diuretics: may cause dangerous hyperkalaemia.
  • NSAIDs (high dose): can reduce renal perfusion and blunt antihypertensive effect.
  • Cyclosporine: increases risk of nephrotoxicity.

Moderate Interactions (Monitor Closely)

  • Diuretics: may enhance antihypertensive effect, requiring dose adjustment.
  • Lithium: can raise lithium levels, necessitating close monitoring.
  • Antidiabetic agents: may need dose modification due to improved glycaemic control.
  • Rifampin: may lower irbesartan plasma concentrations.
  • NSAIDs (low dose): monitor renal function and blood pressure.

Frequently Asked Questions

Irbesartan Tecnigen is prescribed to lower high blood pressure (hypertension) and to protect kidney function in patients with diabetic nephropathy, helping to slow the progression of kidney disease associated with type 2 diabetes.

Irbesartan blocks the angiotensin II type 1 (AT1) receptors, preventing angiotensin II from causing blood vessels to narrow and from stimulating aldosterone release. This results in vasodilation, reduced sodium retention, and lower blood pressure, while also offering renal protective effects.

The specific dose of Irbesartan Tecnigen is determined by the prescribing healthcare professional based on the patient’s medical condition, response to therapy, and other individual factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Irbesartan is classified as Pregnancy Category D, meaning it can cause harm to the developing fetus and should not be used during pregnancy. It is also not recommended while breastfeeding because it may pass into breast milk and affect the infant.

To order Irbesartan Tecnigen, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and necessary import documentation.

Irbesartan belongs to the ARB class, offering blood‑pressure control similar to ACE inhibitors but with a lower incidence of cough. Compared with other ARBs, its efficacy and safety profile are comparable, and it is often chosen for patients who cannot tolerate ACE inhibitors.

Irbesartan Tecnigen should be stored at temperatures below 25 °C, in the original packaging, protected from moisture and direct sunlight. Keeping the product in a dry, cool environment helps maintain its stability and potency.

Irbesartan Tecnigen is taken orally, usually as a tablet swallowed whole with a glass of water. It can be taken with or without food, but patients should follow the dosing schedule prescribed by their healthcare provider.

The most serious risks include angioedema (swelling of the face, lips, tongue, or throat), severe hypotension, acute kidney injury, and hyperkalaemia. Patients should seek immediate medical attention if they experience swelling, faintness, or sudden changes in kidney function.

Irbesartan should not be used by individuals with known hypersensitivity to the drug, pregnant women, patients with bilateral renal artery stenosis, or those with severe hepatic impairment without careful medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Irbesartan

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT